Related Experiment Video

Updated: Jun 14, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Carcinogenesis and therapeutic strategies in thyroid cancer

Zhi-Min Liu1, Ting-Ting Wu, C Andrew van Hasselt

  • 1Department of Biochemistry and Molecular Biology, The School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. liuzm9999@yahoo.com.cn

Current Drug Targets
|March 20, 2010
PubMed

Insights

New targeted therapies are needed for progressive thyroid cancer due to ineffective current treatments. This review explores advancements in thyroid cancer biology and novel anti-thyroid agents for improved patient management.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Current treatments for progressive thyroid cancer show limited efficacy.
  • There is a significant unmet need for novel therapeutic strategies.
  • Advances in understanding thyroid cancer biology reveal potential therapeutic targets.

Purpose of the Study:

  • To review recent developments in thyroid carcinogenesis.
  • To discuss novel anti-thyroid agents in clinical or preclinical development.
  • To integrate insights into thyroid cancer biology with potential therapeutic interventions.

Main Methods:

  • Literature review of thyroid carcinogenesis.
  • Analysis of genetic events and molecular abnormalities in thyroid neoplasms.
  • Evaluation of anti-thyroid agents in clinical trials and preclinical development.

Main Results:

  • Numerous genetic events and signaling pathway alterations drive thyroid cancer progression.
  • Targeted compounds show potential for treating refractory thyroid cancers.
  • Several novel anti-thyroid agents are emerging from research.

Conclusions:

  • Understanding thyroid cancer biology is crucial for developing targeted therapies.
  • Novel anti-thyroid agents offer promising alternatives to traditional treatments.
  • Further research into targeted interventions is warranted for progressive thyroid cancer.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.